API Development and Manufacturing
Novadoz is the business unit of MSN Group that markets the company’s finished dosage products. MSN is one of the fastest growing pharmaceutical companies in India. The company is engaged in the formulation and manufacturing of APIs (active pharmaceutical ingredients). The organization has 10 API manufacturing facilities in Hyderabad which serves over 350 customers including the majority of major US generic pharma companies.
MSN’s API operation has a dedicated R&D and Technology development center that provides state of the art research and manufacturing to more than 300 APIs in 35 therapeutic categories.
The API developing and manufacturing facilities have been FDA audited over 15 times since 2008 without any major observations. MSN Laboratories has applied and received 272 active DMFs (Drug Master Files) making them the second largest supplier in the US Market. Its impressive FDA record of accomplishment, experience, and unwavering commitment to quality makes MSN’s API facilities a preferred & trusted provider by its customers.